May 16, 2012
Research Triangle Park, NC
With the “America Invents Act” and new U.S. patent laws now in effect or being implemented over the next year, emerging pharmaceutical, biotechnology, and medical device companies are asking what are the implications of the changes and how do we adapt?
During the seminar, attendees will gain insight on building a business and patent portfolio strategy that responds to the new first-to-file patent system. Additionally, attendees will learn about the potential advantages under the new patent laws with regard to maintaining certain information as trade secrets.
Pharmaceutical, biotechnology, and medical device business executives; university researchers; and technology transfer officers.
5:00 – 5:30 p.m. Registration
5:30 – 7:00 p.m. Program
7:00 – 8:00 p.m. Reception
North Carolina Biotechnology Center
Dogwood Room
15 T.W. Alexander Drive
Research Triangle Park, NC 27709
Register by Friday, May 11. There is no charge to attend the program. Space is limited, so please register early.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Conference
Boston Intellectual Property Law Association 4th Annual Symposium
April 10-11, 2024
Boston
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.